Skip to content
  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJNeurology
    • VJDementia
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Meeting on the Med 2021 and Meeting On The Med 2021 View overview page

4:25
Building the advanced therapies workforce in the UK
Matthew Durdy • 9 Apr 2021
3:31
The state of investment in cell & gene therapy
Matthew Durdy • 9 Apr 2021
3:41
Improving patient access to advanced therapies: are we ready for them?
Durhane Wong-Rieger • 6 Apr 2021
2:58
ATA188 in EBV+ progressive multiple sclerosis
Pascal Touchon • 7 Apr 2021
2:56
International collaboration in advanced therapies
Amy DuRoss • 8 Apr 2021
2:48
Supply chain management & automation
Amy DuRoss • 8 Apr 2021
2:45
What can the field learn from the COVID-19 pandemic?
Amy DuRoss • 8 Apr 2021
1:14
The importance of specialty medical centers in delivering ATMPs
Paige Bischoff • 11 Mar 2021
4:06
Shaping the future of CMC in cell & gene therapy
Stephen Ward • 14 Apr 2021
3:24
Advancing the sector: training, scalability & materials standardization
Stephen Ward • 14 Apr 2021
3:43
Horizon scanning for the UK cell & gene therapy sector
Stephen Ward • 14 Apr 2021
3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward • 14 Apr 2021
3:06
Targeting solid tumors: SPEAR T-cells & HLA-independent TCRs
Jo Brewer • 7 Apr 2021
1:09
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS
Jo Brewer • 7 Apr 2021
1:22
SURPASS: evaluating the next-generation of SPEAR T-cell therapy
Jo Brewer • 7 Apr 2021
4:23
Off-the-shelf iPSC therapies for solid tumors
Jo Brewer • 7 Apr 2021
  • 1
  • 2
  • 3
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy